QIAGEN N.V. (QGEN) Stock Fundamental Analysis
NYSE:QGEN - New York Stock Exchange, Inc. - NL0015002CX3 - Common Stock - Currency: USD
QGEN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making QGEN a very profitable company, without any liquidiy or solvency issues. QGEN is not valued too expensively and it also shows a decent growth rate. These ratings would make QGEN suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year QGEN was profitable.
In the past year QGEN had a positive cash flow from operations.
Each year in the past 5 years QGEN has been profitable.
In the past 5 years QGEN always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 1.47%, QGEN is doing good in the industry, outperforming 72.73% of the companies in the same industry.
QGEN's Return On Equity of 2.34% is fine compared to the rest of the industry. QGEN outperforms 70.91% of its industry peers.
The Return On Invested Capital of QGEN (7.14%) is better than 78.18% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for QGEN is significantly below the industry average of 13.60%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROIC | 7.14% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
With a decent Profit Margin value of 4.23%, QGEN is doing good in the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Profit Margin of QGEN has declined.
Looking at the Operating Margin, with a value of 25.02%, QGEN belongs to the top of the industry, outperforming 94.55% of the companies in the same industry.
In the last couple of years the Operating Margin of QGEN has grown nicely.
The Gross Margin of QGEN (63.82%) is better than 90.91% of its industry peers.
In the last couple of years the Gross Margin of QGEN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
QGEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
QGEN has less shares outstanding than it did 1 year ago.
QGEN has less shares outstanding than it did 5 years ago.
QGEN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.42 indicates that QGEN is not in any danger for bankruptcy at the moment.
QGEN has a Altman-Z score of 4.42. This is amongst the best in the industry. QGEN outperforms 81.82% of its industry peers.
The Debt to FCF ratio of QGEN is 2.77, which is a good value as it means it would take QGEN, 2.77 years of fcf income to pay off all of its debts.
QGEN has a Debt to FCF ratio of 2.77. This is in the better half of the industry: QGEN outperforms 80.00% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that QGEN is not too dependend on debt financing.
QGEN has a Debt to Equity ratio (0.38) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Altman-Z | 4.42 |
ROIC/WACC0.93
WACC7.66%
2.3 Liquidity
QGEN has a Current Ratio of 3.61. This indicates that QGEN is financially healthy and has no problem in meeting its short term obligations.
QGEN has a Current ratio (3.61) which is comparable to the rest of the industry.
A Quick Ratio of 3.09 indicates that QGEN has no problem at all paying its short term obligations.
QGEN's Quick ratio of 3.09 is in line compared to the rest of the industry. QGEN outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.95% over the past year.
The Earnings Per Share has been growing by 8.25% on average over the past years. This is quite good.
The Revenue has been growing slightly by 0.66% in the past year.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
3.2 Future
QGEN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.10% yearly.
The Revenue is expected to grow by 7.82% on average over the next years.
EPS Next Y8.07%
EPS Next 2Y8.28%
EPS Next 3Y9%
EPS Next 5Y9.1%
Revenue Next Year4.11%
Revenue Next 2Y5.15%
Revenue Next 3Y5.76%
Revenue Next 5Y7.82%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.48, QGEN is valued on the expensive side.
80.00% of the companies in the same industry are more expensive than QGEN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of QGEN to the average of the S&P500 Index (26.32), we can say QGEN is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 18.21, the valuation of QGEN can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QGEN indicates a somewhat cheap valuation: QGEN is cheaper than 80.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, QGEN is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.48 | ||
| Fwd PE | 18.21 |
4.2 Price Multiples
85.45% of the companies in the same industry are more expensive than QGEN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, QGEN is valued cheaper than 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.31 | ||
| EV/EBITDA | 14.25 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QGEN does not grow enough to justify the current Price/Earnings ratio.
QGEN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.54
PEG (5Y)2.48
EPS Next 2Y8.28%
EPS Next 3Y9%
5. Dividend
5.1 Amount
QGEN has a yearly dividend return of 0.53%, which is pretty low.
Compared to an average industry Dividend Yield of 0.51, QGEN pays a better dividend. On top of this QGEN pays more dividend than 92.73% of the companies listed in the same industry.
With a Dividend Yield of 0.53, QGEN pays less dividend than the S&P500 average, which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
5.2 History
QGEN is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.28%
EPS Next 3Y9%
47.11
-0.28 (-0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners86.78%
Inst Owner Change-94.46%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap10.20B
Analysts76.67
Price Target50.55 (7.3%)
Short Float %2.84%
Short Ratio4.12
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.53% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.23%
Min EPS beat(2)-3.85%
Max EPS beat(2)3.38%
EPS beat(4)3
Avg EPS beat(4)1.13%
Min EPS beat(4)-3.85%
Max EPS beat(4)3.38%
EPS beat(8)5
Avg EPS beat(8)1.25%
EPS beat(12)9
Avg EPS beat(12)4.32%
EPS beat(16)13
Avg EPS beat(16)5.2%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.02%
Revenue beat(8)0
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.09%
Revenue beat(16)7
Avg Revenue beat(16)0.75%
PT rev (1m)0.81%
PT rev (3m)-1.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.23%
EPS NY rev (1m)0%
EPS NY rev (3m)1.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)1.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.48 | ||
| Fwd PE | 18.21 | ||
| P/S | 5.16 | ||
| P/FCF | 20.31 | ||
| P/OCF | 15.15 | ||
| P/B | 2.86 | ||
| P/tB | 12.17 | ||
| EV/EBITDA | 14.25 |
EPS(TTM)2.3
EY4.88%
EPS(NY)2.59
Fwd EY5.49%
FCF(TTM)2.32
FCFY4.92%
OCF(TTM)3.11
OCFY6.6%
SpS9.13
BVpS16.47
TBVpS3.87
PEG (NY)2.54
PEG (5Y)2.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROCE | 9.62% | ||
| ROIC | 7.14% | ||
| ROICexc | 9.2% | ||
| ROICexgc | 29.06% | ||
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% | ||
| FCFM | 25.39% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Debt/EBITDA | 1.92 | ||
| Cap/Depr | 84.24% | ||
| Cap/Sales | 8.66% | ||
| Interest Coverage | 20.47 | ||
| Cash Conversion | 96.47% | ||
| Profit Quality | 600.91% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 | ||
| Altman-Z | 4.42 |
F-Score7
WACC7.66%
ROIC/WACC0.93
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
EPS Next Y8.07%
EPS Next 2Y8.28%
EPS Next 3Y9%
EPS Next 5Y9.1%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
Revenue Next Year4.11%
Revenue Next 2Y5.15%
Revenue Next 3Y5.76%
Revenue Next 5Y7.82%
EBIT growth 1Y11.16%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year58.48%
EBIT Next 3Y22.89%
EBIT Next 5Y16.26%
FCF growth 1Y69.33%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y46.6%
OCF growth 3Y1.77%
OCF growth 5Y15.28%